Startup News
Boulder biomedical engineer Jacob Segil is working to bring back a sense of touch for amputees, including veterans of the wars in Iraq and Afghanistan.
Boulder researchers and the spinoff VitriVax Inc., are focused on finding a way to get vaccines to 7.8 billion people. The research team is able to do so with funding, licensing and startup support from Venture Partners at Boulder, the university’s commercialization arm.
Researchers are fast-tracking a new -born technology, SickStick, in hopes of not only helping to curb the current pandemic but also radically change the way we track disease in the future.
The next businesses to make a splash will come out of Colorado’s research institutions, including Boulder. Venture Partners' Managing Director Bryn Rees is featured in the article.
Vu, an assistant professor in the Department of Computer Science, is improving human cognitive functions using an ear-worn device. To bring the technology to customers worldwide later in 2020, he founded Earable Inc., which now has more than 15 employees.
Randolph, a professor in the Department of Chemical and Biological Engineering, founded VitriVax, a Boulder spinout, to commercialize new applications of atomic layer deposition techniques for producing thermally stable vaccines.
Funding will support the ongoing development of a nascent RNA drug screen.
Six Boulder-based startups with ties to Boulder were recognized for their innovation with $1.5 million in grants from the Colorado Office of Economic Development and International Trade.
The companies—Artimus Robotics, Bioloomics, Earable, Emergy, Longpath Technologies, and New Iridium—represent several departments across campus.
Led by its current investors Maverick Ventures and Global Frontier Investments, the funding will be used to advance the development of ColdQuanta’s cold atom Quantum Core technology, the foundation for the company’s development of quantum computers.